The Next Fifty Years: Drug Discovery in the Age of the Computational Self
By: Kosi Gramatikoff, Ed Judge and Klaus Brusgaard
References
- Gramatikoff K. The Authority Vector: A Unified Theory of Civilizational Direction from Transcendence to the Self. PhilPapers. 2026. Available from: https://philpapers.org/rec/GRATAV-2
- Gramatikoff K. AI and the Coming Evaluation Crisis in R&D: How AI Restructures the Economics of Knowledge in Science and Pharma R&D [Asymmetric Epistemic Burden]. Medium. 2026. Available from: https://medium.com/p/e127cf62a9b3
- Gramatikoff K. Asymmetric Epistemic Burden in Academic Research. Medium. 2025. Available from: https://medium.com/p/7f02694e58ab
- Gil Y, Perrault R, et al. Artificial Intelligence Index Report 2026. Stanford Human-Centered Artificial Intelligence (HAI). 2026. Available from: https://hai.stanford.edu/ai-index/2026-ai-index-report
- Ghareeb AE, Chang B, Mitchener L, et al. A multi-agent system for automating scientific discovery. Nature. 2026. Available from: https://doi.org/10.1038/s41586-026-10652-y
- Gottweis J, Weng W-H, Daryin A, et al. Accelerating scientific discovery with an AI co-scientist. Nature. 2026. Available from: https://doi.org/10.1038/s41586-026-10644-y
- Aygün E, Belyaeva A, Comanici G, et al. An AI system to help scientists write expert-level empirical software. Nature. 2026. Available from: https://doi.org/10.1038/s41586-026-10658-6
- Lu C, et al. Towards end-to-end automation of AI research (The AI Scientist). Nature. 2026. Available from: https://doi.org/10.1038/s41586-026-10265-5
- Coral DE, Sargent JL, Carrasco-Zanini J, et al. Five te-nets for advancing evidence-based precision medicine. Nat Med. 2026. Available from: https://doi.org/10.1038/s41591-026-04309-6
- Kim J, Hu C, Moufawad El Achkar C, Black LE, Douville J, Larson A, et al. Patient-customized oligonucleotide therapy for a rare genetic disease. N Engl J Med. 2019. Available from: https://doi.org/10.1056/NEJMoa1813279
- Adam D. The AI co-scientist is here. Nat Med. 2026. Available from: https://doi.org/10.1038/s41591-026-04275-z
- U.S. Food and Drug Administration. Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products. Draft Guidance. FDA. 2025. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-artificial-intelligence-support-regulatory-decision-making-drug-and-biological
- Saratkar SY, Langote M, Kumar P, et al. Digital twin for personalized medicine development. Front Digit Health. 2025. Available from: https://doi.org/10.3389/fdgth.2025.1583466
- Mazuz K, Biswas S. Towards the future of personalized medicine: digital twin technology. Explor Digit Health Technol. 2026. Available from: https://doi.org/10.37349/edht.2026.101181
- Vallee A. Multi-scale digital twins for personalized medicine. Front Digit Health. 2026. Available from: https://doi.org/10.3389/fdgth.2026.1753906
- Menon G, Malave B, Mhaske M, et al. Digital twin technologies in medicine: innovations, barriers, and future directions. Innov Health Sci. 2026. Available from: https://doi.org/10.1016/j.inhs.2025.100043
- Vallée A. Digital twins for personalized medicine require epidemiological data and mathematical modeling. J Med Internet Res. 2025. Available from: https://doi.org/10.2196/72411
- U.S. Food and Drug Administration. AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information. Fed Regist. 2026. Available from: https://www.federalregister.gov/documents/2026/04/29/2026-08281
- Nature Editorial Board. AI scientists are changing research: institutions, funders and publishers must respond. Nature. 2026. Available from: https://www.nature.com/articles/d41586-026-00934-w
- Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630(8016):493-500. Available from: https://doi.org/10.1038/s41586-024-07487-w
- Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583-589. Available from: https://doi.org/10.1038/s41586-021-03819-2
- Fang Z, Ran H, Zhang Y, Chen C, Lin P, Zhang X, Wu M. AlphaFold 3: an unprecedented opportunity for fundamental research and drug development. Precis Clin Med. 2025. Available from: https://doi.org/10.1093/pcmedi/pbaf015
- Shoshan Y, Raboh M, Ozery-Flato M, et al. MAMMAL, Molecular Aligned Multi-Modal Architecture and Language for biomedical discovery. npj Drug Discov. 2026. Available from: https://doi.org/10.1038/s44386-026-00047-4
- Zheng Y, Koh HY, Ju J, et al. Large language models for drug discovery and development. Patterns. 2025. Available from: https://doi.org/10.1016/j.patter.2025.101346
- Zhao X, et al. Application of artificial intelligence large language models in drug target discovery. Front Pharmacol. 2025. Available from: https://doi.org/10.3389/fphar.2025.1597351
- Ferreira FJN, Carneiro AS. AI-driven drug discovery: a comprehensive review. ACS Omega. 2025. Available from: https://doi.org/10.1021/acsomega.5c00549
- Serrano DR, Luciano FC, Anaya BJ, et al. Artificial intelligence applications in drug discovery and drug delivery: revolutionizing personalized medicine. Pharmaceutics. 2024;16(10):1328. Available from: https://doi.org/10.3390/pharmaceutics16101328
- Zhou L, Ling H, Fu C, et al. Autonomous agents for scientific discovery: orchestrating scientists, language, code, and physics. Nat Mach Intell. 2025. Available from: https://doi.org/10.48550/arXiv.2510.09901
- Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov. 2004;3(8):711-715. Available from: https://doi.org/10.1038/nrd1470
- Ma C, Zhang H, Rao Y, et al. AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential. npj Digit Med. 2025. Available from: https://doi.org/10.1038/s41746-025-02198-6
- Sergi CM, Sesso HD. Artificial intelligence and the future of clinical trials. Contemp Clin Trials Commun. 2025. Available from: https://doi.org/10.1016/j.conctc.2025.101545
- Qoronfleh MW. Precision medicine in medical technology (medtech): the future of healthcare through personalized devices. Health Technol (Berl). 2026. Available from: https://doi.org/10.1007/s12553-026-01065-y
- Paci MM, Saha T, Djassemi O, et al. Smart closed-loop drug delivery systems. Nat Rev Bioeng. 2025. Available from: https://doi.org/10.1038/s44222-025-00328-z
- Duan H, Peng S, He S, et al. Wearable electrochemical bio-sensors for advanced healthcare monitoring. Adv Sci. 2024. Available from: https://doi.org/10.1002/advs.202411433
- Abhinav V, Basu P, Verma SS, et al. Advancements in wearable and implantable BioMEMS devices: transforming healthcare through technology. Micromachines (Basel). 2025;16(5):522. Available from: https://doi.org/10.3390/mi16050522
- Xiao Y, Li Y, Jing X, et al. Organoid models in oncology: advancing precision cancer therapy and vaccine development. Cancer Biol Med. 2025. Available from: https://doi.org/10.20892/j.issn.2095-3941.2025.0127
- Fontes M, Garcez D, Ruivo J, et al. Glioblastoma zebrafish avatars guide therapeutic decisions in a patient with gliosarcoma: a case report. Commun Med (Lond). 2025;6:53. Available from: https://www.nature.com/articles/s43856-025-01314-7
- Sutanto H, Fetarayani D. Integrating artificial intelligence into small molecule development for precision cancer immunomodulation therapy. npj Drug Discov. 2026. Available from: https://doi.org/10.1038/s44386-025-00029-y
- Lopes AB, Rodrigues CF, Rodrigues FAM. From algorithm to medicine: AI in the discovery and development of new drugs. AI (Basel). 2026;7(1):26. Available from: https://doi.org/10.3390/ai7010026
- Khan SN, Danishuddin, Khan MWA, Guarnera L, Akhtar SMF. Multi-modal AI in precision medicine: integrating genomics, imaging, and EHR data for clinical insights. Front Artif Intell. 2026. Available from: https://doi.org/10.3389/frai.2025.1743921
- Zack M, Stupichev DN, Moore AJ, et al. Artificial intelligence and multi-omics in pharmacogenomics: a new era of precision medicine. Mayo Clin Proc Digit Health. 2025. Available from: https://doi.org/10.1016/j.mcpdig.2025.100246
- Srivastava R. Advancing precision oncology with AI-powered genomic analysis. Front Pharmacol. 2025. Available from: https://doi.org/10.3389/fphar.2025.1591696
- Hussain A, Dershem M, Nasr J, et al. Why pharmacoepidemiology must embrace patient data sovereignty and decentralized technologies. Blockchain Healthc Today. 2026. Available from: https://blockchainhealthcaretoday.com/index.php/journal/article/view/495
- Kumar HA, Venkatram CP, Saran N, et al. Decentralised digital health ecosystems: a unified architecture for AI-enhanced medical record management. Front Digit Health. 2025. Available from: https://doi.org/10.3389/fdgth.2025.1685628
- Levy N. Responsibility is not required for authorship. J Med Ethics. 2024;51(4):e109912. Available from: https://doi.org/10.1136/jme-2024-109912
- Wang Z, Gong M. Cross-disciplinary analysis of AI policies in academic peer review. Learn Publ. 2026. Available from: https://doi.org/10.1002/leap.2035
- Gramatikoff K. The Emergence of AI-Native Science: From Tools to Autonomous Research Systems. PhilPapers. 2026. Available from: https://philpapers.org/rec/GRATEO-83
- Tobias AV, Wahab A. Autonomous self-driving laboratories: a review of technology and policy implications. R Soc Open Sci. 2025. Available from: https://doi.org/10.1098/rsos.250646
- Hartung T. AI, agentic models and lab automation for scientific discovery: the beginning of scAInce. Front Artif Intell. 2025. Available from: https://doi.org/10.3389/frai.2025.1649155
- Dai Y, Chan H, Vriza A, et al. Adaptive AI decision interface for autonomous electronic material discovery. Nat Chem Eng. 2025. Available from: https://doi.org/10.1038/s44286-025-00318-3
DOI: https://doi.org/10.2478/ebtj-2026-0018 | Journal eISSN: 2564-615X
Language: English
Page range: 242 - 257
Published on: Jul 23, 2026
Published by: European Biotechnology Thematic Network Association
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Kosi Gramatikoff, Ed Judge, Klaus Brusgaard, published by European Biotechnology Thematic Network Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.